David Hui is a Professor with tenure and the Director of Supportive and Palliative Care Research at the University of Texas MD Anderson Cancer Center. He is a dual-certified practicing medical oncologist and palliative care specialist. He is a principal investigator in multiple clinical trials funded by the National Cancer Institute (R01x3 and R21x1), the National Institute of Nursing Research (R21), the American Cancer Society, the Cancer Prevention and Research Institute Of Texas, and others. He obtained a B.S. and an M.S. at the University of British Columbia. He received an MD at the University of British Columbia. He was a Clinical Fellow at the Medical Oncology, British Columbia Cancer Agency, Vancouver, from 2006 to 2008. He is a Standing Member of an NIH grant review panel (Interdisciplinary Clinical Care in Specialty Care Settings). He is a Board Member of the Multinational Association of Supportive Care in Cancer (MASCC). He was also the Chair of the 2020 European Society for Medical Oncology (ESMO) Breathlessness Guideline and a Co-Chair of the 2021 American Society of Clinical Oncology (ASCO) Dyspnea Guideline.